Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3 High Growth Swedish Stocks With Strong Insider Ownership

In This Article:

As global markets react to economic data and shifting investor sentiment, Sweden's stock market remains a focal point for those seeking growth opportunities. In this environment, companies with high insider ownership often stand out due to the confidence shown by those closest to the business. In this article, we explore three high-growth Swedish stocks where insiders have significant stakes, indicating strong internal belief in their potential and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

24.8%

Magle Chemoswed Holding (OM:MAGLE)

14.9%

72.2%

Biovica International (OM:BIOVIC B)

18.7%

73.8%

Yubico (OM:YUBICO)

37.5%

43.8%

InCoax Networks (OM:INCOAX)

18.1%

104.9%

BioArctic (OM:BIOA B)

34%

104.2%

KebNi (OM:KEBNI B)

37.8%

90.4%

Calliditas Therapeutics (OM:CALTX)

11.6%

52.9%

SaveLend Group (OM:YIELD)

23.3%

103.4%

edyoutec (NGM:EDYOU)

13.4%

63.1%

Click here to see the full list of 88 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden and has a market cap of SEK14.35 billion.

Operations: BioArctic's revenue segment primarily consists of SEK252.21 million from its biotechnology operations.

Insider Ownership: 34%

BioArctic, a growth company with high insider ownership, is forecast to see its revenue grow at 39.1% per year, significantly outpacing the Swedish market's 1.1%. The company is expected to become profitable within three years and has seen more insider buying than selling recently. Despite volatility in its share price, analysts agree the stock could rise by 100.9%. Recent approval of Leqembi for Alzheimer's treatment in Hong Kong further strengthens BioArctic's growth prospects.

OM:BIOA B Earnings and Revenue Growth as at Aug 2024
OM:BIOA B Earnings and Revenue Growth as at Aug 2024

Haypp Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Haypp Group AB (publ) is an online retailer specializing in tobacco-free nicotine pouches and snus products across Sweden, Norway, the rest of Europe, and the United States, with a market cap of SEK2.96 billion.

Operations: The company's revenue segments are comprised of SEK2.42 billion from Core and SEK834.20 million from Growth, with a Segment Adjustment of SEK8.06 million.